Compare Bandhan Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.75
2.09
NAV
₹10.99
₹46.97
Fund Started
10 Nov 2025
25 Jun 2018
Fund Size
₹322.43 Cr
₹6624.58 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
-
7.27%
3 Year
-
23.93%
5 Year
-
15.49%
Equity
96.71%
96.05%
Cash
3.29%
3.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.11% |
Apollo Hospitals Enterprise Ltd. | 8.08% |
Cipla Ltd. | 6.82% |
Max Healthcare Institute Ltd. | 6.30% |
Divi's Laboratories Ltd. | 6.12% |
JB Chemicals & Pharmaceuticals Ltd. | 4.27% |
Dr. Reddy's Laboratories Ltd. | 4.21% |
Aurobindo Pharma Ltd. | 3.92% |
Glenmark Pharmaceuticals Ltd. | 3.42% |
Dr. Lal Pathlabs Ltd. | 2.96% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 Nov 2025
25 Jun 2018
